The Herpes Virus, a potential Drug candidate for breast cancer and Ovarian

A team of scientists discovered a potential treatment for Italy healing ovarian and breast cancer. They managed to develop genetic engineering results the herpes virus which can block dissemination of ovarian and breast cancer. Scientists believe the virus has been programmed not to mention harming human beings and forms the basis for the treatment of cancer in the future.

Herpes simplex Virus (HSV) will attack the aggressive ovarian and breast tumors, which have more than one active Her-2 gene. The Virus is injected in the body engineering mice with tumors of the breast and ovary, significantly impeding the spread of cancer cells are capable of. The spread of metastatic cancer or, as reported by the Huffingtonpost.com, is the leading cause of death in cancer patients.

Professor Gabriella Campadelli-Fiume, leader of the research from the University of Bologna, Italy, said, "many laboratories around the world are using the virus as a weapon to attack specific cancer cells called onkolitik virus."

According to him, in addition to patient safety issues in the use of onkolitik virus, clinical studies showed the virus onkolitik was only effective at a fraction of the tumor. "Our Study is the first to be reprogrammed herpes virus to enter tumor cells and other cells not infected yet still retain the capacity for the destruction of the virus herpes simplex."

The research is reported in the online journal Public Library of Science Pathogens include viruses that prevent the spread of the tumor through the abdominal cavity. Despite the spread of cancer to the brain and ovaries was greatly reduced, the herpes virus is not able to protect the lungs from cancer.